Imalgene 100 mg/ml, süstelahus koertele ja kassidele
Imalgene 100 mg/ml, süstelahus koertele ja kassidele
Not authorised
- Ketamine
Product identification
Medicine name:
Imalgene 100 mg/ml, süstelahus koertele ja kassidele
Active substance:
- Ketamine
Target species:
-
Dog
-
Cat
Route of administration:
-
Intravenous use
-
Intramuscular use
Product details
Active substance and strength:
-
Ketamine100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN01AX03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1447
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 2/12/2021
